Cite
MLA Citation
K.A. Rogers et al.. “PHASE 2 STUDY OF ACALABRUTINIB IN IBRUTINIB‐INTOLERANT PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA.” Hematological oncology, vol. 37, n.d., pp. 60–61. http://access.bl.uk/ark:/81055/vdc_100086206953.0x000048